What If You Could Use Your Own Tumor Data to Guide Cancer Treatment?
Two patients can walk into a clinic with the exact same diagnosis and receive the exact same drug. One goes into remission, while the other sees no change…
Why?
The answer often lies in the invisible differences within our DNA.
While standard care treats the diagnosis, it doesn’t always account for the unique biological drivers of the individual.
This is the gap that Astron Health aims to fill.
As a precision oncology company, Astron helps patients and clinicians bridge the gap between standard care and personalized strategy.
Co-founded by Dr. Padman Vamadevan and Ben Whately, Astron uses genomic and molecular data to identify carefully selected repurposed medications and adjunct therapies tailored to your specific biology.
The goal isn’t to replace your oncology team, but to turn the complex data you likely already have into a clear, actionable roadmap.
If you’ve ever wondered why a treatment worked for someone else but not for you, the answer lies in the data and Astron helps you find it.
What Standard Cancer Treatments Often Miss
According to Dr. Vamadevan;
“We’re really quite good at killing cancer cells. We’re not very good at stopping them from coming back.”
Much of standard cancer treatment is built around short-term results, such as whether tumors shrink or scans look clear.
That can be important, especially early on.
But it doesn’t always get at the underlying biological factors that allow cancer to come back or change over time.
This is where personalized cancer care comes in, filling the gap between short-term results and long-term outcomes.
What Is Astron Health Doing Differently?
Instead of taking a universal approach to treatment, Astron Health looks at the specific molecular makeup of each person’s tumor.
As Dr. Vamadevan explains, two patients can have the same diagnosis and similar scans, but at the molecular level their cancers look very different.
This helps explain why they do not have the same prognosis.
Astron focuses on the biological pathways that are driving a tumor’s growth, looks for potential weak spots, and then considers whether there are existing medications that might realistically target those vulnerabilities.
Astron’s recommendations are not meant to replace standard treatment, but rather to work alongside it.
Using Genomic Testing to Personalize Cancer Treatment
Genomic and molecular testing can offer deeper insight into how a person’s cancer actually behaves, not just what it’s called.
Rather than simply confirming a diagnosis, these tests help reveal what’s driving an individual tumor and where it may be vulnerable information that can point to options standard treatments don’t always address.
In many cases, patients have already undergone this kind of testing as part of their care, with results sitting in their medical records, ready to be analyzed.
How Astron’s Personalized Cancer Analysis Works
One of the core challenges in modern cancer care: there is simply too much data for any one person to process. As Co-founder Whately puts it,
No oncologist can have a look at 100,000 papers in their entire lifetime.
It is clear that the challenges are not only medical, but technological and that AI could help.
Astron’s approach begins by reviewing existing pathology and genomic reports that patients may already have.
With the help of AI tools, the tumor’s test results are compared against existing studies to narrow down which current drugs or supplements may target the specific weak points.
Those options are then carefully reviewed by Astron’s medical team, so the final plan reflects both advanced analysis and human expertise.
Is Astron The Right Fit For You?
Astron is built for those who refuse to settle for “standard” and are looking for a proactive path forward. You are a fit if:
You’ve been told you’ve hit a “dead end.”
If genomic testing came back with no actionable results and you’re looking for the next level of insight, Astron finds what others miss.
You are stable and want to stay that way.
If you’ve finished standard treatment and want a personalized, data-backed strategy to prevent recurrence.
You feel overwhelmed by “supplement noise.”
If you’re tired of conflicting advice and long lists of pills, and you want a grounded, scientific way to decide what actually belongs in your body.
The Bottom Line
At the core of Astron’s mission, one message comes through clearly:
cancer care does not have to and should not be a one-size-fits-all approach.
Patients don’t have to rely on guesswork or future breakthroughs to start asking better questions today.
